Does Aetna (CVS Health) Cover Metformin?
A clinical and coverage guide to Aetna (CVS Health) metformin coverage, prior authorization criteria, formulary tiers, step therapy requirements, and appeal pathways for type 2 diabetes and prediabetes.
Metformin
48 source-based articles maintained by the HealthRX.com Editorial Team.
48articles
7topic areas covered
Jul 10, 2025latest review
Metformin library
Showing 48 of 48 clinical reviews.
Does Blue Cross Blue Shield (Federated) Cover Metformin?
A complete guide to Blue Cross Blue Shield (Federated) coverage for metformin, including formulary tiers, prior authorization, step therapy, appeals, and out-of-pocket cost options.
Does Humana Cover Metformin? Formulary Tiers, Prior Auth, and Appeal Steps
Find out whether Humana covers metformin for type 2 diabetes and off-label uses, which formulary tier it sits on, prior-authorization rules, and how to appeal a denial.
Does Kaiser Permanente Cover Metformin?
A complete guide to Kaiser Permanente metformin coverage, formulary tier, prior authorization requirements, step therapy rules, and how to appeal a denial, with clinical context from UKPDS 34 and current ADA guidelines.
Does Medicare Advantage Cover Metformin?
A complete guide to Medicare Advantage metformin coverage, formulary tiers, prior authorization, step therapy, and how to appeal a denial, with clinical context.
Does State Medicaid Cover Metformin? Formulary, Prior Auth, and Appeal Guide
A state-by-state guide to Medicaid coverage of metformin for type 2 diabetes and prediabetes, including formulary tiers, prior authorization criteria, step therapy rules, and how to appeal a denial.
Does UnitedHealthcare Cover Metformin?
Metformin coverage under UnitedHealthcare is plan-specific. Learn how to verify the exact product, tier, pharmacy, and prior-authorization requirements without relying on stale coverage claims.
Januvia vs Metformin Cost: Price and Evidence Compared
Metformin costs $4-$20/month generic; Januvia runs $450-$550 branded. Metformin also has stronger long-term outcomes data, per major guidelines.
Metformin Adult (30 to 49) Dosing: The Complete Clinical Guide
Evidence-based metformin dosing for adults aged 30 to 49, covering starting doses, titration schedules, maximum doses, renal thresholds, and real-world considerations for working-age patients with type 2 diabetes or prediabetes.
Metformin and Food/Supplement Interactions to Avoid
Metformin food effects differ between IR and XR. Review alcohol, B12, calcium and supplement questions with formulation-specific evidence and study limits.
Metformin Contraindications and Safety for Ages 30-49
Metformin contraindications include poor kidney or liver function and heavy alcohol use. See who's at risk and what your labs mean before dosing.
Metformin Dosage for Type 2 Diabetes: 500mg to 2,000mg
Standard metformin dosing starts at 500mg with meals, up to 2,000mg daily max. Lowers HbA1c 1.0-1.5 points; backed by UKPDS 34 trial data.
Metformin Dosing for Older Adults (50 to 64): Evidence-Based Guidelines
How to dose metformin safely in adults aged 50 to 64, including starting doses, titration schedules, renal adjustments, and monitoring strategies based on clinical trial evidence.
Metformin Dosing for Young Adults (Ages 18 to 29): A Complete Clinical Guide
Evidence-based metformin dosing guide for young adults aged 18 to 29, covering starting doses, titration schedules, fertility considerations, PCOS use, and ADA guidelines with primary source citations.
Metformin eGFR Dosing Thresholds by Kidney Function
Metformin dosing by eGFR: full dose above 60, reduced dose 30-59 with monitoring, contraindicated below 30 mL/min/1.73 m2 per FDA label.
Metformin for Metabolic Syndrome: Evidence, Dosing, and Clinical Use
A guide to using metformin for metabolic syndrome: what the trial data shows, how to dose it, who qualifies, and what side effects to watch for.
Metformin for NAFLD / MASLD: Evidence, Dosing, and Clinical Use
A guide to using metformin in NAFLD / MASLD patients: what the trials actually show, how to dose it, who benefits most, and where newer agents fit in.
Metformin for Prediabetes: Evidence, Dosing, and Who Should Take It
A guide to metformin for prediabetes: what the DPP trial showed, who qualifies, how to dose, and what side effects to expect.
Metformin Future Formulations & Pipeline: What's Coming Beyond the Standard Tablet
A deep dive into metformin's next-generation formulations, pipeline compounds, extended-release mechanisms, and emerging combination strategies backed by primary clinical evidence.
Metformin Geriatric (65+) Dosing: Evidence-Based Guide to Safe Prescribing
How to dose metformin safely in adults 65 and older. Covers renal-adjusted starting doses, titration schedules, eGFR thresholds, B12 monitoring, and deprescribing criteria backed by primary-source evidence.
Metformin Geriatric (65+) Monitoring: Lab Schedules, Dose Adjustments, and Safety Checks
Evidence-based monitoring guide for metformin in adults 65 and older. Covers renal function tracking, B12 screening, lactic acidosis risk, deprescribing criteria, and recommended lab intervals.
Metformin History & Development: From French Lilac to First-Line Diabetes Drug
A deep-dive into metformin's 100-year journey from plant alkaloid to the world's most-prescribed diabetes medication, covering its pharmacological roots, key clinical trials, and mechanism of action.
Metformin in Hepatic Impairment: Dosing by Child-Pugh Class
Metformin is avoided in severe liver disease (Child-Pugh C or AST/ALT over 3x ULN); mild-to-moderate cases may use cautious low-dose therapy.
Metformin in Pregnancy and Lactation: Safety Evidence, Guidelines, and Clinical Decisions
Evidence-based review of metformin safety during pregnancy and breastfeeding, including MiG trial data, placental transfer, breast milk levels, and current ACOG/ADA guideline positions.
Metformin in Special Populations: Transplant, HIV, Elderly, Pregnancy, and More
A clinician-level guide to metformin dosing, safety, and pharmacology in transplant recipients, people living with HIV, older adults, pregnant patients, and other special populations. Evidence-based, PubMed-cited.
Metformin Interactions with Other Medications
Metformin is cleared renally, not by liver enzymes. Contrast dye, dolutegravir, topiramate, alcohol and cimetidine pose the biggest risks.
Metformin Labs to Monitor - eGFR, B12 and A1c Schedule
Metformin labs to monitor: eGFR at least yearly, B12 every 1-2 years after 4+ years on the drug, plus A1c targets and lactic acidosis risk for adults 50-64.
Metformin Manufacturing, Supply & Shortage History
A clinical deep-dive into metformin's manufacturing origins, global supply chain, FDA shortage events, NDMA recalls, and current availability for type 2 diabetes treatment.
Metformin Mechanism of Action: The Full Molecular Pathway Explained
A physician-level breakdown of how metformin works, from mitochondrial Complex I inhibition and AMPK activation to hepatic glucose suppression, gut signaling, and microbiome remodeling.
Metformin Microdosing Protocols: What the Evidence Actually Shows
A clinical review of metformin microdosing protocols for type 2 diabetes, prediabetes, longevity, and off-label use. Covers dosing thresholds, tolerability data, titration schedules, and what current guidelines do and do not support.
Metformin Missed-Dose Protocol: What to Do When You Skip a Dose
Missing one metformin dose usually causes only a modest fasting glucose rise of 15 to 30 mg/dL, not a crisis. Never double up; repeated gaps raise HbA1c.
Metformin Monitoring for Adults (30 to 49): Lab Schedule, Side Effects, and When to Adjust
Evidence-based metformin monitoring guide for adults aged 30 to 49. Covers baseline labs, follow-up intervals, renal function tracking, B12 screening, and red flags that signal a dose change.
Metformin Monitoring for Young Adults (Ages 18 to 29): A Complete Clinical Guide
Everything a young adult (18-29) needs to know about metformin monitoring: which labs to check, how often, warning signs, fertility considerations, and how to stay safe long-term.
Metformin Monitoring Schedule: Labs & Exams You Actually Need
Evidence-based metformin monitoring schedule covering HbA1c, renal function, B12, hepatic panels, and CBC. Includes timing, thresholds, and when to adjust or stop.
Metformin Off-Label Uses with Evidence Levels
A clinician-grade review of metformin's off-label applications beyond type 2 diabetes, ranked by strength of evidence from randomized trials, meta-analyses, and guideline endorsements.
Metformin Overdose and Accidental Excess Dose: Clinical Management Guide
A guide to metformin overdose, accidental excess dosing, metformin-associated lactic acidosis (MALA), and evidence-based emergency management protocols.
Metformin Patent Field & Generic Timeline
A detailed history of metformin patents, generic approvals, extended-release formulations, and the current competitive field for the world's most prescribed diabetes drug.
Metformin Pharmacogenomics & Genetic Variability: What Your DNA Tells Us About This Drug
A clinician-level review of metformin pharmacogenomics, covering SLC22A1, SLC47A1, ATM, and other variants that explain why response to metformin differs so dramatically between patients.
Metformin Pharmacokinetics (ADME): Absorption, Distribution, Metabolism, and Excretion
A physician-level review of metformin pharmacokinetics covering oral bioavailability, transporter-mediated uptake via OCT1/OCT2, zero hepatic metabolism, and renal tubular secretion. Includes dosing implications for eGFR thresholds.
Metformin Real-World Evidence: What Registries and RWE Studies Actually Show
A deep dive into metformin real-world evidence from major registries and RWE studies, covering mechanism, cardiovascular outcomes, cancer signals, and how registry data compares to RCT findings.
Metformin Regulatory Status: US, EU, Canada, and UK, Plus How It Works
A clinician-level guide to metformin's approval history, current regulatory standing, and mechanism of action across the US, EU, Canada, and UK, with sourcing limitations flagged for editorial review.
Metformin Safety in Geriatric Patients (65+): Dosing, Risks, and Monitoring
Evidence-based guide to metformin safety in adults 65 and older, covering renal dosing, lactic acidosis risk, B12 monitoring, drug interactions, and deprescribing criteria.
Metformin Safety in Older Adults Ages 50 to 64
A clinical guide to metformin safety for adults aged 50 to 64, covering dosing, kidney thresholds, lactic acidosis risk, drug interactions, and monitoring protocols in the context of current FDA labeling and diabetes guidelines.
Metformin Safety in Young Adults (Ages 18 to 29): What Patients and Clinicians Need to Know
A comprehensive, evidence-based review of metformin safety for young adults aged 18, 29, covering dosing, side effects, contraindications, fertility, and long-term monitoring backed by clinical trial data.
Metformin Safety Signals and FDA Actions: What Prescribers and Patients Should Know
Metformin and vitamin B12 deficiency: DPPOS found 4.3% deficiency vs 2.3% placebo; ADA advises periodic B12 checks. FDA boxed warning: lactic acidosis.
Metformin Storage and Expiration: Check the Exact Product
Metformin storage and shelf life depend on the formulation, package, and label. Use this evidence-based record for heat, moisture, expiration, liquid, and recall questions.
Stopping Metformin: A Safety Hold, Treatment Change or Remission Check?
Why metformin may be stopped, when a temporary hold matters, and how to interpret glucose and A1c results after a treatment change.
Switching From or To Metformin: Evidence-Based Protocols for Every Scenario
Clinical protocols for switching between metformin and other glucose-lowering drugs, including GLP-1 agonists, SGLT2 inhibitors, sulfonylureas, and insulin. Covers timing, dose bridging, and monitoring.